We’re here to decrease the public health threat from COVID-19 and
mitigate the pandemic’s economic impact until a vaccine is widely
available. A rapid, reliable, inexpensive and easy-to-use at-home
antigen test will significantly reduce virus transmission,
particularly by asymptomatic patients, while enabling people with
negative results to engage in day-to-day activities – from going to
work, going to school, shopping, visiting a relative or vacationing.
Widespread use of rapid tests is currently limited by the need for
trained clinical operators or specialized laboratory equipment to
ensure that tests are performed and interpreted accurately, the
Gauss-Cellex Rapid At-Home Test can be performed in 15 minutes by an
individual, in any location, with a smartphone.
Please note, this technology is currently investigational and not
authorized or approved by FDA.